- Home
- SEB vs DNLI Comparison
SEB vs DNLI Comparison
Compare SEB & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEB
- DNLI
- Stock Information
- Founded
- SEB 1918
- DNLI 2013
- Country
- SEB United States
- DNLI United States
- Employees
- SEB N/A
- DNLI N/A
- Industry
- SEB Farming/Seeds/Milling
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SEB Industrials
- DNLI Health Care
- Exchange
- SEB Nasdaq
- DNLI Nasdaq
- Market Cap
- SEB 2.5B
- DNLI 2.1B
- IPO Year
- SEB N/A
- DNLI 2017
- Fundamental
- Price
- SEB $3,919.98
- DNLI $15.65
- Analyst Decision
- SEB
- DNLI Strong Buy
- Analyst Count
- SEB 0
- DNLI 15
- Target Price
- SEB N/A
- DNLI $33.62
- AVG Volume (30 Days)
- SEB 2.2K
- DNLI 1.8M
- Earning Date
- SEB 10-28-2025
- DNLI 08-11-2025
- Dividend Yield
- SEB 0.24%
- DNLI N/A
- EPS Growth
- SEB N/A
- DNLI N/A
- EPS
- SEB 143.20
- DNLI N/A
- Revenue
- SEB $9,496,000,000.00
- DNLI N/A
- Revenue This Year
- SEB N/A
- DNLI N/A
- Revenue Next Year
- SEB N/A
- DNLI $802.87
- P/E Ratio
- SEB $26.36
- DNLI N/A
- Revenue Growth
- SEB 4.70
- DNLI N/A
- 52 Week Low
- SEB $2,365.00
- DNLI $10.57
- 52 Week High
- SEB $3,932.71
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- SEB 79.82
- DNLI 62.54
- Support Level
- SEB $3,477.11
- DNLI $15.20
- Resistance Level
- SEB $3,814.14
- DNLI $15.79
- Average True Range (ATR)
- SEB 87.89
- DNLI 0.72
- MACD
- SEB 6.08
- DNLI 0.14
- Stochastic Oscillator
- SEB 87.74
- DNLI 83.51
About SEB Seaboard Corporation
Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.